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Background—Atherosclerotic lesions are believed to grow via the recruitment of bone marrow–derived monocytes.
Among the known murine monocyte subsets, Ly-6Chigh monocytes are inflammatory, accumulate in lesions
preferentially, and differentiate. Here, we hypothesized that the bone marrow outsources the production of Ly-6Chigh
monocytes during atherosclerosis.
Methods and Results—Using murine models of atherosclerosis and fate-mapping approaches, we show that hematopoietic
stem and progenitor cells progressively relocate from the bone marrow to the splenic red pulp, where they encounter
granulocyte macrophage colony-stimulating factor and interleukin-3, clonally expand, and differentiate to Ly-6Chigh
monocytes. Monocytes born in such extramedullary niches intravasate, circulate, and accumulate abundantly in
atheromata. On lesional infiltration, Ly-6Chigh monocytes secrete inflammatory cytokines, reactive oxygen species, and
proteases. Eventually, they ingest lipids and become foam cells.
Conclusions—Our findings indicate that extramedullary sites supplement the hematopoietic function of the bone marrow
by producing circulating inflammatory cells that infiltrate atherosclerotic lesions. (Circulation. 2012;125:364-374.)
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Monocytes are myeloid leukocytes that circulate in theblood and patrol the vascular endothelium.1–4 During
inflammatory diseases, monocytes accumulate in target sites and
mature to macrophages or dendritic cells. Although monocytes
are thought to arise exclusively in the bone marrow, hematopoi-
etic stem and progenitor cells (HSPCs), which are developmen-
tally upstream, readily mobilize from their bone marrow niches,
accumulate in the periphery, and differentiate.5,6 Although this
phenomenon of extramedullary hematopoiesis is known to give
rise to erythrocytes, platelets, granulocytes, and dendritic cells, it
remains unknown whether HSPCs can yield monocytes outside
the bone marrow. Likewise, the mechanisms that govern HSPC
proliferation and differentiation and the eventual fate of the
various progeny remain elusive.
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Atherosclerosis is a chronic disease characterized by the
accumulation of lipids and leukocytes in the arterial vessel
wall.7–10 Among leukocytes, monocytes are essential to the
development and exacerbation of the disease.4,11,12 On lesional
accumulation and as a consequence of ingesting lipids abun-
dantly, monocyte-derived macrophages become foam cells, the
key culprits of atherosclerotic complications. Of the 2 recog-
nized murine monocyte subsets, Ly-6Chigh monocytes have been
shown to accumulate preferentially in growing lesions and to
give rise to macrophages in atheromata.12,13 Ly-6Chigh mono-
cytes are also believed to convert to Ly-6Clow monocytes,14,15
but this conversion is compromised during atherosclerosis.12 It
remains unknown whether extramedullary hematopoiesis in
general and the extramedullary production of Ly-6Chigh mono-
cytes specifically contribute to the development of
atherosclerosis.
In this study, we focused on experimental atherosclerosis to
determine whether lesion-accumulating monocytes can have
extramedullary origins. Our data show that the spleen, which
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contains a reservoir of undifferentiated monocytes in the steady
state,16–18 becomes monocytopoietic during atherosclerosis.
Methods
Animals
C57BL/6J (wild-type [wt]), B6.SJL-PtprcaPep3b/BoyJ (CD45.1),
C57BL/6-Tg(UBC-GFP)30Scha/J (green fluorescent protein–positive
[GFP]), B6.Cg-Tg(ACTB-mRFP1)1F1Hadj/J (red fluorescent pro-
tein–positive [RFP]), apolipoprotein E–deficient (ApoE/) mice
(B6.129P2-Apoetm1Unc), and low-density lipoprotein receptor–deficient
(LDLR/)ApoB48/ (B6;129S-Apobtm2Sgy Ldlrtm1Her/J) male and
female mice were purchased from The Jackson Laboratories. All
protocols were approved by the Animal Review Committee at Massa-
chusetts General Hospital. More details are given in the online-only
Data Supplement.
Animal Models and In Vivo Interventions
Splenectomy, spleen transplantation, parabiosis, and adoptive trans-
fer of cells are described in detail in the Experimental Procedures
section in the online-only Data Supplement. Mice were injected
intravenously with blocking antibodies, with clodronate liposomes,
or with oxidized LDL, as described in the online-only Data
Supplement.
Flow Cytometry
Antibodies used in the study are listed in the online-only Data
Supplement. Data were acquired on an LSRII (BD Biosciences) and
analyzed with FlowJo version 8.8.6 (Tree Star, Inc). Cells were
sorted on a BD FACSAria II (BD Biosciences).
Histology
Aortas and spleens were excised, embedded in optimal-cutting-
temperature compound (Sakura Finetek), and flash-frozen in isopen-
tane and dry ice. Frozen 5-m-thick sections were used in all
staining protocols. Immunofluorescence staining was carried out
with the protocols described in the online-only Data Supplement.
Intravital Microscopy
Intravital microscopy was performed on exteriorized spleens of live
animals. Time-lapse images were captured to visualize the behavior
of cells. Details of the procedure are given in the online-only Data
Supplement.
Statistics
Results are expressed as meanSEM. Statistical tests included
unpaired, 2-tailed Student t test with the Welch correction for
unequal variances and 1-way ANOVA followed by the Bonferroni
comparison test. Values of P0.05 were considered to
denote significance.
Results
The Spleen Contributes Ly-6Chigh Monocytes to
the Growing Atheroma
We have previously shown that the spleen contains a mono-
cyte reservoir that mobilizes in response to acute injury,17 but
the role of this reservoir in chronic inflammatory diseases
such as atherosclerosis is unknown. We chose to investigate
a possible link between the splenic reservoir and atheroscle-
rosis in ApoE/ mice. Immunofluorescent staining, which
provides information on spatial distribution, showed expan-
sion of CD11b cells throughout the red pulp of ApoE/
mice (Figure 1A), indicating enlargement of this reservoir.
Enumeration of splenic leukocytes in wt C57BL/6 mice and
ApoE/ mice consuming a diet high in fat and cholesterol
(HCD) revealed dramatic differences between the groups:
ApoE/ mice had a marked increase in myeloid but not
lymphoid cell number (Figure Ia and Ib in the online-only
Figure 1. Splenic myeloid cells infiltrate atherosclerotic lesions. A, Immunofluorescence (IF) of CD11b cells (red) in spleens of C57BL/6
(wt) and apolipoprotein E–deficient (ApoE/) mice consuming a high-cholesterol diet (HCD) for 20 weeks. Data show that the red pulp
myeloid component enlarges during atherosclerosis and pushes the white pulp clusters away from each other. B, Size of the monocyte
reservoir in ApoE/ mice consuming a chow diet for 20 weeks, ApoE/ mice consuming an HCD 20 weeks, and ApoE/ mice con-
suming an HCD for 20 weeks and then injected with clodronate liposomes 1 day earlier (n2–10). C, Presence of CD45.1 cells in the
blood of CD45.2 mice that received CD45.1 spleens by transplantation. D, Spleen transplantation from CD45.1 ApoE/ donors
consuming an HCD to CD45.2 ApoE/ recipients. Data show direct accumulation and differentiation of splenic Ly-6Chigh monocytes in
aortic lesions in 1 day. One of 11 representative experiments is shown. E, Spleen transplantation from CD45.1 ApoE/ donors con-
suming chow and from CD45.1 ApoE/ donors consuming an HCD and then injected with clodronate liposomes. Data show negligible
accumulation of splenic monocytes in aortic lesions in these controls. F, IF on the aortic root with antibodies against CD45.1 (green)
and CD11b (red) and the merge of the 2 (yellow). DAPI depicts nuclei (blue). Arrows point to CD11b cells of splenic origin. For all flow
cytometric plots, the ticks represent 0, 102, 103, 104, 105 fluorescence units, except for axes labeled “cell no.” or “SSC,” for which the
ticks represent 0, 50 000, 100 000, 150 000, 200 000, and 250 000 fluorescence units.
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Data Supplement), a finding that complements previous
work.12 Within the myeloid compartment of the spleen, both
monocyte and neutrophil numbers increased (Figure Ic in the
online-only Data Supplement). We also detected an expan-
sion of monocytes and neutrophils in the spleens of LDLR/
ApoB48/ mice consuming a Paigen diet, indicating that
the phenomenon is ApoE independent (Figure Id in the
online-only Data Supplement).
To address whether the spleen mobilizes monocytes during
atherogenesis, we transplanted spleens from CD45.1 ApoE/
mice to recently splenectomized 30-week-old CD45.2 ApoE/
mice that had consumed an HCD for 20 weeks. The transplan-
tation procedure anastomoses splenic and recipient vessels,
preserves blood flow and organ integrity,17 and does not alter the
relative proportion of endogenous leukocytes in the spleen, bone
marrow, and blood (Figure Ie in the online-only Data Supple-
ment). The transplanted spleens resembled endogenous spleens
in size and cellularity, had the characteristic purplish-red color,
and were well perfused (Figure If in the online-only Data
Supplement). Spleens of CD45.1 ApoE/ mice consuming an
HCD for 20 weeks were large and enriched with myeloid cells
(Figure 1B). As a control, we also transplanted spleens from
CD45.1 ApoE/ mice consuming a chow diet (chow) because
they contained small spleens and relatively small myeloid
reservoirs (Figure 1B) and spleens from CD45.1 ApoE/ mice
consuming an HCD that had their reservoirs depleted with
clodronate liposomes (Figure 1B).
Transplantation of CD45.1 ApoE/ mice consuming an
HCD for 20 weeks led to a large accumulation of spleen-derived
monocytes, but not macrophages, in the recipient blood
(4.71052105 monocytes in blood; Figure 1C). After 24
hours, 4515% of the monocytes found in the blood were
splenic derived. Although we focused our analysis on monocytes
and progeny (CD11bLin1; Figure Ia in the online-only Data
Supplement), other cells such as neutrophils also accumulated
(data not shown). In accordance with the blood data, we
observed a substantial population of CD45.1 cells in the
recipient aorta consisting of F4/80low monocytes and F4/80high
macrophages (Figure 1D), thus indicating that spleen-
experienced F4/80low monocytes accumulated in lesions and
matured to F4/80high macrophages locally. The observed contri-
bution of 19% in 24 hours is an underestimation given that an
endogenous pool of macrophages already reside in the aorta
before transplantation. By focusing on monocytes in the aorta
that had recently proliferated, we estimated that the spleen
contributed30% of monocytes in 1 day. Remarkably, 100% of
monocytes arriving from the spleen (ie, CD45.1) were Ly-
6Chigh, whereas monocytes arriving from all other sources (ie,
CD45.2) contained a mixture of Ly-6Chigh and Ly-6Clow mono-
cytes. Transplantation of spleens from either of the 2 controls led
to a very low accumulation of monocytes and progeny in the
aorta (Figure 1E). Importantly, the total number of aortic
monocytes was similar in ApoE/ HCD spleen recipients
compared with age- and diet-matched controls that did not
receive a spleen by transplantation (Figure Ig in the online-only
Data Supplement), indicating that the transplantation procedure
did not interfere with cell accumulation in the aorta. The finding
is expected because the transplantation experiments consisted of
removing the endogenous spleen and thus represented splenic
exchange rather than supplementation. The intima of aortic root
lesions contained spleen-derived myeloid cells of mixed mor-
phology readily identified by CD45.1 immunofluorescence (Fig-
ure 1F). The spleen therefore contributes inflammatory
Ly-6Chigh monocytes to the growing atheromata.
Spleen-Experienced Monocytes Express
Pro–Interleukin-1, Have Proteolytic Capacity,
Contribute Reactive Oxygen Species, and Give
Rise to Lipid-Laden Macrophages in Atheromata
Monocyte-derived macrophages in atheromata secrete in-
flammatory cytokines, express proteolytic enzymes, contrib-
ute reactive oxygen species, and ingest lipids. Each of these
functions profoundly influences lesion evolution. Inflamma-
tory cytokines and reactive oxygen species propagate inflam-
mation; proteolysis remodels the extracellular matrix; and
lipid uptake yields foam cells.7 We therefore sought to
determine whether spleen-experienced monocytes and mac-
rophages exhibit these properties. We compared spleen-
experienced monocytes and their descendent macrophages
with monocytes and macrophages that arrived from all
sources by transplanting CD45.1 ApoE/ spleens to
CD45.2 ApoE/ animals for 2 days, as shown in Figure 1.
For simplicity, we call these spleen-experienced monocytes
and their descendent macrophages “splenic” and those arriv-
ing from all sources medullary. It is important to note,
however, that at least some of the medullary cells might have
experienced the spleen before accumulating in lesions.
Evaluating inflammatory cytokine expression focused on
interleukin (IL)-1, a monocyte product implicated in many
aspects of atherogenesis.19 Aortic cells in ApoE/ HCD
mice expressed a higher proportion of pro–IL-1 compared
with wt controls (Figure IIa and IIb in the online-only Data
Supplement), reflecting the higher inflammatory burden of
these animals. Spleen transplantation revealed similar pro–
IL-1 expression among splenic (CD45.1) and medullary
(CD45.2) monocytes, suggesting that the inflammatory
capacity of splenic monocytes is comparable to that of their
counterparts (Figure 2A). Splenic (CD45.1) aortic macro-
phages remained pro–IL-1  at proportions similar to those
of monocytes but at higher proportions than CD45.2 mac-
rophages. This indicates that aortic monocytes and macro-
phages of splenic origin are at least as, if not more, inflam-
matory as their CD45.2 counterparts. To investigate
proteolysis, we injected spleen recipients with a protease-
activatable fluorescent sensor that reports on cysteinyl ca-
thepsin activity in vivo.20,21 At the cellular level, most
lesional monocytes and macrophages of splenic origin
(CD45.1) exhibited proteolytic activity, and comparison
with lesional monocytes and macrophages accumulating from
the bone marrow (CD45.2) revealed a similar proportion
(83% versus 78%; 98% versus 85% were positive for
Prosense-680) of signal (Figure 2B). Monocytes had less
proteolytic activity when residing in the bone marrow and
spleen, indicating that proteolysis coincides with activation in
destination sites (Figure IIc in the online-only Data Supple-
ment). To measure cellular redox states, we used an intracel-
lular probe that measures oxidative stress.22 Regardless of
origin, monocytes and macrophages expressed reactive oxy-
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gen species, although macrophages derived from spleen-
experienced monocytes expressed them at somewhat lower
levels (Figure 2C). Finally, we asked whether spleen-
experienced monocytes can give rise to lesional foam cells.
Circulating monocytes of either origin accumulated DiI-
oxidized LDL to the same extent (Figure IId in the online-
only Data Supplement) and aortic atheromata contained large
myeloid cells of splenic origin that took up Oil Red O (Figure
2D and 2E and Figure IIe in the online-only Data Supple-
ment), indicating that the spleen contributes foam cell
precursors.
The spleen is a secondary lymphoid organ that supports
multiple functions: It contains T and B cells that participate in
adaptive immunity and macrophage and dendritic cell subsets
that scavenge erythrocytes and screen for blood-borne infec-
tions.23 In animal models, splenectomized mice24,25 and
hamsters depleted of monocytes with clodronate liposomes
develop larger lesions.26 We therefore wondered whether and
how splenectomy alters the lesional monocyte/macrophage/
foam cell content. As expected, lesions in female mice
splenectomized for 12 weeks were larger (Figure 2F) as
assessed by hematoxylin and eosin staining (Figure IIf in the
online-only Data Supplement). However, the lesions ap-
peared to be less cellular, prompting us to evaluate their
content with macrophage markers. Staining for Mac3,
CD11b, and F4/80 revealed that aortic root sections in
Figure 2. Splenic cells are inflammatory and shape lesional evolution. A, Spleen transplantation from CD45.1 apolipoprotein E–deficient
(ApoE/) to CD45.2 ApoE/ mice. Expression of pro–interleukin (IL)-1 on monocytes and macrophages directly ex vivo (ie, unstimu-
lated). Contour plots show pro–IL-1 expression gated on lesional monocytes and macrophages of splenic (CD45.1, red) or other source
(ie, bone marrow) (CD45.2, blue) origin. The control density plots (black) represent isotype controls. B, Contour plots show protease activity
gated on lesional monocytes and macrophages of splenic (CD45.1, red) or other source (ie, bone marrow; CD45.2, blue) origin. The control
density plots (black) are gated on all leukocytes. C, Contour plots show the presence of reactive oxygen species on lesional monocytes and
macrophages of splenic (CD45.1, red) or other source (ie, bone marrow; CD45.2, blue) origin. The control density plots (black) are gated
on cells that did not receive the probe. Representative plots in A through C of at least 2 independent experiments are shown. D, Spleen
transplantation for 10 days. Data show immunofluorescence on the aortic root with antibodies against CD45.1 (splenic cells, green), F4/80
(macrophages, red), and their merge (yellow). DAPI depicts nuclei (blue). Arrows point to F4/80 cells of splenic origin. E, Oil Red O (ORO)
staining of the same section as in D shows colocalization of ORO with spleen-derived macrophages. F, Splenectomy of ApoE/ high-cho-
lesterol diet (HCD) mice for 12 weeks. Data show enumeration of total lesion size with hematoxylin and eosin. G, Representative Mac3
expression on aortic root sections in control and splenectomized ApoE/ HCD mice. H, Enumeration of CD11b, ORO, F4/80, and Mac3
areas on aortic root sections in control and splenectomized ApoE/ HCD mice. I, Enumeration of the necrotic core size in the same groups
as above. J, Representative ORO staining in the same groups as above. K, Flow cytometry of digested aortas. Dot plots show cellular distri-
bution from control and splenectomized ApoE/ HCD mice. The monocyte/macrophage gate is shown. L, Total number of monocytes and
macrophages/dendritic cells enumerated by flow cytometry (meanSEM; n5–11) *P0.05.
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splenectomized mice contained fewer monocyte/macro-
phages (Figure 2G and 2H and Figure IIg in the online-only
Data Supplement) but had larger acellular areas (Figure 2I).
Accordingly, cellular Oil Red O areas were smaller in
splenectomized mice (Figure 2H and 2J). We detected no
differences in collagen content, as measured by Masson
trichrome (Figure IIh in the online-only Data Supplement)
and no differences in smooth muscle cell content (Figure IIi
in the online-only Data Supplement). Flow cytometry of
digested aortas confirmed that lesions of splenectomized
mice contained fewer monocytes/macrophages (Figure 2K
and 2L).Our studies are in accordance with the observation
that, when monocyte supply is reduced, lesions become larger
and less cellular.26 Thus, the spleen provides a surplus of cells
that serve to shape the evolving lesion.
The Spleen Contains Proliferating Myeloid Cell
Progenitors That Give Rise to Their Progeny
In Vivo
The cell tracking experiments described thus far may simply
reflect production of monocytes in the bone marrow, their
circulation through the spleen, and their eventual accumula-
tion in the lesions. We therefore sought to determine whether
the spleen can produce monocytes from progenitors. In vitro,
splenocytes of ApoE/ HCD mice formed many more
granulocyte/macrophage colonies than wt controls (Figure
3A), indicating clonal myeloid cell proliferation. Compared
with wt controls, ApoE/ HCD mice contained numerous
HSPCs, including LSK (Lin2 Sca-1 c-kit) cells and
common myeloid progenitors, as well as granulocyte and
macrophage progenitors (GMPs), which are the most com-
mitted progenitors known to give rise to monocytes and
neutrophils4 (Figure 3B and Figure IIIa in the online-only
Data Supplement). Common lymphoid progenitors did not
increase in ApoE/ HCD mice, indicating a preference
toward the myeloid lineage in the spleen (Figure IIIa in the
online-only Data Supplement). GMP enumeration over 30
weeks of diet showed continued growth in the spleen. The
GMP population in the bone marrow also grew, but less
markedly and transiently (Figure 3C). Indeed, in many older
animals, the GMP population in the spleen exceeded that of
the bone marrow. Notably, although the spleen also contained
macrophage and dendritic cell progenitors,27 the aorta and
para-aortic lymph nodes were virtually devoid of HSPCs
(data not shown). In keeping with the expanded reservoir, the
spleens of LDLR/ApoB48/ mice also contained higher
numbers of GMPs (Figure IIIb in the online-only Data
Supplement). These findings demonstrate that the spleens of
atherosclerotic mice contain the requisite myelopoietic cells.
Figure 3. The spleen contains proliferating myeloid cell progenitors that give rise to their progeny in vivo. A, Colony-forming units–granulo-
cytes and macrophages (CFU-GM) show colony formation in spleens of wild-type (wt) and apolipoprotein E–deficient (ApoE/) high-choles-
terol diet (HCD) mice (meanSEM; n4). *P0.05. B, Phenotypic analysis of granulocyte and macrophage progenitors (GMPs) in spleens of
wt and ApoE/ HCD mice. C, Enumeration of GMP in spleens and bone marrow of ApoE/ mice fed an HCD for up to 30 weeks. Linear
regression was performed. D, Adoptive transfer of green fluorescent protein–positive (GFP) GMPs to wt and ApoE/ HCD mice. Data
show GFP cells in spleens 5 days after transfer. E, Enumeration of data above. Data show the fold increase from wt to ApoE/ HCD mice
of adoptively transferred GFP cells in the bone marrow (BM) and spleen (data shown are pooled from 2 independent experiments). F,
CD45.1 spleens from ApoE/ HCD mice were transplanted to asplenic CD45.2 ApoE/ HCD mice for 10 days. Data show chimerism of
GMPs in spleens 10 days after transplantation. G, Cell cycle analysis of CD45.1 and CD45.2 GMP in transplanted spleens shown in F.
Numbers indicate percentage of cells in S/G2/M phase (meansSEM; n4). H, Monocyte accumulation in aortic tissue of the mice described
in F and G. Representatives of 2 independent experiments are shown.
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To test for monocytopoiesis in vivo, we injected 1105
highly purified GFP-expressing GMP (Figure IIIc in the
online-only Data Supplement) into either ApoE/ HCD or
wt mice and enumerated GFP cells 5 days later. Consider-
ably more GFP cells accumulated in the spleens of ApoE/
HCD mice than in the controls (Figure 3D and 3E). Among
these cells, we detected progenitors and differentiated
CD11bGr1 monocytes and neutrophils (Figure IIId in the
online-only Data Supplement), which indicates GMP expan-
sion. The number of GFP cells accumulating in the bone
marrow, however, was similar in wt and ApoE/ HCD mice
(Figure 3E). This similarity likely reflects a preference for
mobilized progenitors to seed the spleen in atherosclerosis
(progenitors were injected intravenously).
To demonstrate that the spleen contributes rather than
simply collects monocytes, we performed spleen transplanta-
tion experiments for longer durations. The monocyte half-life
is estimated at a few hours to 1 to 2 days,11,28 and adoptive
transfer of 5106 sorted monocytes by a procedure that
allows their retrieval 1 day later12 failed to yield any cells in
lesions, blood, or spleen 5 days later. We therefore reasoned
that if monocytes and their progenitors reside in the spleen
briefly or simply circulate through its fenestrated paren-
chyma, spleen transplantation would result in a rapid and
complete cell turnover. If, however, the spleen produces
monocytes, it should maintain progenitors and monocytes
from the original animal for a period exceeding 2 days. In
accordance with the second possibility, CD45.2 ApoE/
HCD mice that received CD45.1 ApoE/ spleens 10 days
earlier contained 3.2106 GMPs, of which 25% were still
CD45.1 (Figure 3F), and many were proliferating (Figure
3G). The aortas of these mice also contained numerous
CD45.1 monocytes and macrophages (Figure 3H). Impor-
tantly, that 75% of GMPs that were CD45.2 in these animals
indicates that the bone marrow continuously supplies and
replenishes the splenic progenitor pool. In contrast, transplan-
tation of naı¨ve spleens, which do not contain progenitors,
resulted in complete turnover of the monocyte pool in 2 days.
Thus, if the bone marrow is the upstream source of hemato-
poietic cells, the spleen is a seeding ground for an amplifi-
cation cascade during inflammation. Together, our findings
indicate that the spleen contains proliferating myeloid cell
progenitors that give rise to their progeny in vivo.
Splenic Monocytopoiesis Gives Rise to
Lesion-Infiltrating Monocytes
Having established that the spleen contains proliferating
hematopoietic progenitors, we next sought to determine more
directly whether the spleen supports monocytopoiesis. We
injected GFP GMPs into age- and diet-matched spleen-
containing and asplenic ApoE/ HCD mice. Compared with
controls, asplenic recipients accumulated fewer GFP
CD11b cells in the blood and aorta (Figure 4A and 4B). In
the aorta, among the GFP cells, we found differentiated
monocytes and mature macrophages but not progenitors,
which would appear in the lower-left quadrant
(CD11bMHCII/CD11c/F4/80; Figure 4C), indicating a
direct and spleen-dependent link from hematopoietic progen-
itors to tissue descendants. We confirmed these flow cytom-
etry tracking experiments by detecting adoptively transferred
CD45.1 F4/80 cells microscopically on tissue sections
(Figure 4D).
To confirm the role of the spleen in maintaining the aortic
pool of monocytes, we joined CD45.1 to CD45.2 mice by
parabiosis (Figure 4E), a technique that establishes a shared
circulation by which bone marrow HSPCs can seed partner
tissues.5,6,17,28 Two weeks after parabiont separation, the
percent of myeloid cell chimerism in wt aortas was low
(5%) and spleen independent (Figure 4E). This finding
supports the observation that, under normocholesterolemic
conditions, the spleen does not produce monocytes.17 In
contrast to wt mice, the aortas of spleen-containing ApoE/
HCD animals showed a 3-fold increase in chimerism. Strik-
Figure 4. Splenic monocytopoiesis gives rise to lesion-infiltrating
monocytes. A, Adoptive transfer of green fluorescent protein–posi-
tive (GFP) granulocyte and macrophage progenitors (GMPs) to
apolipoprotein E–deficient (ApoE/) high-cholesterol diet (HCD)
mice with or without their spleen. Data show GFP CD11b cells
retrieved from blood and aorta 5 days after transfer. B, Enumera-
tion of data above (data shown are pooled from 2 independent
experiments). *P0.05. C, Differentiation of GFP GMPs into
lesional macrophages. A representative contour plot shows that
GFP cells that were injected as GMPs have accumulated in
lesions as monocytes and matured to macrophages. D, CD45.1
GMPs were adoptively transferred to ApoE/ HCD mice, and the
aorta was harvested 5 days after transfer. A representative picto-
graph shows CD45.1 (GMP-derived, green), F4/80 (macrophages,
red), and their merge (yellow) in the intima. E, CD45.1 and CD45.2
wild-type (wt) or ApoE/ HCD mice were joined in parabiosis for
3 weeks, separated, splenectomized (or not), and assessed for chi-
merism 2 weeks later. Data show chimerism for CD11b cells in
the aorta (meanSEM; n4).
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ingly, splenectomy decreased this chimerism by nearly 50%.
These data demonstrate, by an independent approach, that the
spleen contributes myeloid cells to the atherosclerotic aorta.
Granulocyte Macrophage Colony-Stimulating
Factor and IL-3 Promote Survival and
Proliferation of Progenitor Cells and
Their Progeny
The growth factors granulocyte macrophage colony-
stimulating factor (GM-CSF) and IL-3 can stimulate hema-
topoiesis, particularly emergency hematopoiesis,29 but their
role in atherosclerosis is poorly understood.30–32 Recent
observations in experimental atherosclerosis that HSPCs
increase the common receptor subunit for GM-CSF and
IL-333 prompted us to investigate the influence of these
cytokines on myelopoiesis. GM-CSF– and IL-3–producing
cells increased preferentially in the spleen during atheroscle-
rosis (Figure 5A). In the spleen, the red pulp of ApoE/
HCD mice contained numerous GM-CSF– and IL-3–produc-
ing cells that stained specifically for the growth factors on
tissue sections (Figure 5B and Figure IVa in the online-only
Data Supplement) and costained for the leukocyte marker
CD45 by flow cytometry (Figure IVb in the online-only Data
Supplement). Negligible levels of GM-CSF and IL-3 cells
were detected in the steady-state spleens. Colony-forming
assays showed that GM-CSF and IL-3 were sufficient to drive
myelopoiesis of splenic progenitors (Figure IVc in the online-
only Data Supplement). We therefore injected antibodies
Figure 5. Granulocyte macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-3 control survival and proliferation of
myeloid progenitors and progeny in atherosclerosis. A, Enumeration of GM-CSF– and IL-3–producing cells by flow cytometry in the
spleen and bone marrow in wild-type (wt) and apolipoprotein E–deficient (ApoE/) high-cholesterol diet (HCD) mice. Data show a pref-
erential increase of GM-CSF and IL-3–producing cells in the spleen (meanSEM; n5). *P0.05. B, Presence of GM-CSF– and IL-3–
producing cells in the red pulp of wt and ApoE/ HCD mice. C, Effect of IL-3 and GM-CSF neutralization on endogenous splenic
granulocyte and macrophage progenitors (GMPs). Data show percent of cells in subG1 and total number of GMPs in spleen
(meanSEM; n4–5). D, Effect of IL-3 and GM-CSF neutralization on the development of myeloid cells after green fluorescent pro-
tein—positive (GFP) GMP pulse chase. Data show GFP CD11bGr1 cells in the spleen and blood (meanSEM; n4–5). E, Effect
of IL-3 and GM-CSF neutralization on apoptosis and proliferation of endogenous monocytes and neutrophils in the spleen
(meanSEM; n4–5). F, Effect of IL-3 and GM-CSF neutralization on the endogenous CD11bGr1 repertoire in the spleen and blood
(meanSEM; n4–5). *P0.05 vs wt (A, B) or HCD isotype (C–F). G, Colony-forming units granulocyte-macrophage (CFU-GM) in the
spleen. Data show that, in the absence of cytokines, colonies do not form in the spleen, that GM-CSF and IL-3 are sufficient for colony
formation, and that a single dose of anti–GM-CSF and anti–IL-3 attenuates colony formation in vitro (meanSEM; n2).
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against GM-CSF and IL-3 on 5 consecutive days and evalu-
ated the myeloid lineage in the spleen, bone marrow, and
blood in vivo using 4 approaches. First, we analyzed splenic
GMPs. Neutralization of IL-3, GM-CSF, or both increased
the proportion of GMPs undergoing apoptosis in situ (as
measured by DNA content) and correspondingly decreased
their total number in the spleen (Figure 5C). Second, we
performed pulse-chase experiments that, as in those depicted
in Figures 3 and 4, involved the transfer and retrieval of
GFP cells. Neutralization of IL-3, GM-CSF, or both pre-
vented the appearance of numerous myeloid cells in the
spleen and blood (Figure 5D). Third, we evaluated
the survival and proliferation of mature myeloid cells in the
spleen. Again, neutralization increased the proportion of in
situ dying monocytes and neutrophils and decreased their
local proliferation (Figure 5E). Finally, we evaluated the
endogenous number of myeloid cells in spleen and blood and
found that neutralization attenuated splenic and blood mono-
cytosis and neutrophilia by up to 80% (Figure 5F). In vitro
confirmatory experiments showed that myelopoiesis was
attenuated with only a single dose of GM-CSF– and IL-3–
neutralizing antibodies (Figure 5G). Expectedly, the dramatic
decrease in vivo resulted not only from local effects on the
spleen, but also from effects on the bone marrow (Figure IVc
in the online-only Data Supplement). These data demonstrate
that GM-CSF and IL-3 orchestrate the survival and prolifer-
ation of myeloid progenitors and their descendants in the
bone marrow and spleen in atherosclerosis.
Extramedullary Hematopoiesis Occurs in Response
to Peritoneal Endotoxin Challenge and Can Be
Visualized In Vivo
Experiments thus far have shown that, in experimental athero-
sclerosis, HSPCs accumulate in the spleen and proliferate in
response to GM-CSF and IL-3 and the spleen contributes
monocytes to the growing atheromata. We next sought to
determine whether the process occurs in a different model and
whether it can be visualized in vivo. Mice that received lipo-
polysaccharide daily for 4 days developed visibly larger spleens
(Figure Va in the online-only Data Supplement) containing
plenty of monocytes (11-fold expansion over steady state) and
neutrophils (23-fold expansion; Figure Vb in the online-only
Data Supplement) that resided in the red pulp (Figure Vc in the
online-only Data Supplement). To evaluate whether the spleen
contributes newly made neutrophils and monocytes in this
model, we first enumerated hematopoietic progenitor cells. In
response to lipopolysaccharide, GMPs expanded in the spleen
(62-fold; Figure Vd in the online-only Data Supplement). The
progenitors proliferated vigorously (47% were in S or G2 phase
of the cell cycle at a given time; Figure Ve in the online-only
Data Supplement) and gave rise to granulocyte macrophage
colony-forming units (Figure Vf in the online-only Data
Supplement).
We therefore tested whether splenic GMPs give rise to their
progeny. Pulse-chase experiments involving the intravenous
transfer of GFP- or RFP-expressing GMPs to nonirradiated (wt)
C57BL/6 mice that were naı¨ve or that received lipopolysaccha-
ride permitted us to track cell fate by flow cytometry and
intravital microscopy. GMPs injected into naı¨ve mice gave rise
to only a few progeny (Figure 6A). Injection of GMP to mice
that received lipopolysaccharide, in contrast, led to marked
cellular expansion. Three days after transfer, the fluorescent (in
this case, GFP) cells in the spleen were still mostly CD11b
Gr1 progenitors, although a few fluorescent neutrophils and a
few Ly-6Chigh monocytes (CD11b Gr1 cells) emerged in the
circulation (Figure 6A). Three to 5 days later (day 6–8), the
fluorescent cells in the spleen and blood were almost exclusively
CD11b Gr1 neutrophils with a few monocytes but not
progenitors, mature macrophages, or dendritic cells (Figure 6A
and 6B). Enumeration revealed significant expansion of neutro-
phils and monocytes in response to lipopolysaccharide in the
spleen and blood (Figure 6C). The bone marrow contained
numerous GFP progeny, but as reported in the atherosclerosis
model, there was no increase in their number in response to
lipopolysaccharide. These data show that escalation of the
neutrophil and monocyte response in response to endotoxin is
associated with an increase in biologically active progenitors in
the spleen.
Intravital microscopy showed that GMPs gave rise to clusters
of cells that resided outside the blood vessels in the red pulp
(Figure 6D). In this pulse-chase experiment, clusters appeared 3
days after adoptive transfer, increased in size by 8 days, and
disappeared by 12 days (Figure Vg and Vh in the online-only
Data Supplement), which is in keeping with the expected
lifespan of GMPs.34 GFP GMPs and RFP GMPs coinjected in
equal numbers (Figure 6E) gave rise to clusters that were
exclusively red or exclusively green, indicating that GMPs
seeded the spleen, proliferated clonally, and differentiated lo-
cally (Figure 6F and Figure Vi–Vk in the online-only Data
Supplement). Time-lapse imaging of representative clusters
showed that locally produced cells can intravasate and thus
contribute to the systemic repertoire (Figure 6G). To enumerate
this contribution, mice were subjected either to splenectomy
(Figure 6H) or to spleen transplantation (Figure 6I). Both
approaches revealed that a substantial number of myeloid cells
accumulating in the peritoneum were of splenic origin. The cells
were inflammatory, as evidenced by the expression of tumor
necrosis factor- (Figure 6J). Together, these data reveal that
extramedullary sites such as the spleen can produce circulating
monocytes and neutrophils that accumulate in their respective
inflammatory destinations. The model that describes the findings
of this study is shown in Figure 7.
Discussion
The motivation for the present study rested on 2 landmark
articles published in the 1960s. The first laid the foundation
that HSPCs circulate in the blood rather than simply reside in
the bone marrow,35 whereas the second argued that, in the
steady state, the bone marrow is the exclusive monocyte
production site.36 Multiple studies since have enriched our
understanding of these processes. Extramedullary hematopoi-
esis occurs in development and in a number of genetic and
myeloproliferative conditions.37–41 It involves several dis-
crete steps: (1) Bone marrow HSPCs mobilize; (2) mobilized
HSPCs seed extramedullary sites; and (3) seeded HSPCs
proliferate and mature. The cell types that have been de-
scribed to arise through extramedullary hematopoiesis are
terminally differentiated, and many are tissue resident. Mono-
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cytes, on the other hand, are intermediate, circulating cells,
developmentally downstream of HSPCs but upstream of
dendritic cells and macrophages.2 Our study places extramed-
ullary hematopoiesis in a larger context not only because it
shows that a GM-CSF– and IL-3–rich splenic environment
can produce monocytes and neutrophils that then circulate but
also because it illustrates an extramedullary cascade in which
HSPC proliferation, differentiation, and terminal maturation
are compartmentalized in different organs. In atherosclerosis,
our data imply, the bone marrow outsources the production of
circulating leukocytes.
Of all the organs, the spleen may be an ideal outsource
destination. The organ has an open circulation, allowing fast
exchange with the blood,23 yet it is capable of cell retention
through myriad adhesive ligands.42,43 The organ can accom-
modate vast quantities and fluctuations of cells, especially in
the red pulp. It also allows the rapid exit of undifferentiated
monocytes, indicating that entry into its parenchyma neither
Figure 6. Extramedullary hematopoiesis gives rise to monocytes in response to repeated peritoneal endotoxin challenge. A, Cartoon
depicts a pulse-chase experiment in which green fluorescent protein—positive (GFP) granulocyte and macrophage progenitors
(GMPs) were adoptively transferred to wild-type (wt) C57BL/6 mice that remained naı¨ve or were injected with lipopolysaccharide (LPS).
A representative plot of at least 3 independent experiments is shown. B, GFP GMPs were adoptively transferred to wt C57BL/6 mice
injected with LPS. Data are representative of at least 3 independent experiments. C, Enumeration of GFP CD11bGr1 cells adop-
tively transferred as GFP GMPs 8 days earlier and retrieved from host spleen and blood of naı¨ve or inflammatory mice (meanSEM;
n3–8). *P0.05. D, Intravital microscopy pictograms of the splenic red pulp depict clusters of GFP cells adoptively transferred intra-
venously 8 days earlier into inflammatory (LPS-injected) mice. Vasculature is shown in red; the scale is depicted with white bars. Data
are representative of at least 3 independent experiments. E, Cartoon depicts the experimental design for the coinjection of equal num-
bers of GFP GMPs and red fluorescent protein–positive (RFP) GMPs into C57BL/6 mice injected with LPS. F, Green and red clusters
in the subcapsular red pulp 5 days after injection of equal numbers of GFP GMPs and RFP GMPs. Vasculature is shown in blue; the
scale is depicted by a white bar. Data are representative of at least 3 independent experiments. G, A prototypic departing cell is shown
to intravasate and enter the circulation. H, Accumulation of myeloid cells in splenectomized animals. Mice received LPS and were
either splenectomized or subjected to sham surgery. Four days later, peritoneal CD11bGr1 cells were enumerated. I, Spleen trans-
plantation from CD45.1 donors to CD45.2 recipient mice. Donors either were naı¨ve or received LPS. The graph shows the total number
of splenic CD11bGr1 that had accumulated in the peritoneum. J, Expression of intracellular tumor necrosis factor- (TNF). Histo-
grams show TNF expression on stimulated cells gated on CD11bGr1 cells of splenic (CD45.1, red) or other source (ie, bone mar-
row) (CD45.2, blue) origin. Data are representative of at least 2 independent experiments.
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forces differentiation nor precludes recirculation.17 Thus,
location, elasticity, and architecture render the spleen a
perfect seeding ground for the emergency production of
inflammatory cells.
It is unknown whether extramedullary hematopoiesis is
important in the development of human atherosclerosis. The
extent to which the spleen contributes to disease, however,
has received some attention. The organ may be dispensable,
but it is not unimportant. In humans, splenectomy heightens
the risk of infection and ischemic heart disease, probably as a
result of multiple mechanisms involving platelets, B cells, T
cells, and many of the other components that constitute the
organ.44 The observations made here in response to hyper-
cholesterolemia or endotoxin indicate a role for the spleen in
supplying Ly-6Chigh monocytes, which are known to be
inflammatory and proteolytic. We show that, by eliminating
this splenic source, lesions become less cellular, although
how this particular profile translates to lesion stability re-
quires further study. Future studies also need to elucidate how
specific splenic functions can be targeted therapeutically and
how other functions such as the protective function of B1 B
cells24 can be spared.
That extramedullary generation of Ly-6Chigh monocytes
occurs during atherosclerosis, when hypercholesterolemia
forces a continuous leukocyte supply, is worth further dis-
cussion. The steady-state spleen houses a reservoir of undif-
ferentiated monocytes that are, in the absence of neighboring
splenic HSPCs, bone marrow derived. The contribution of
extramedullary monocytopoiesis during inflammation may be
exclusively numeric; with repetitive demand, the organism
outsources the production of otherwise identical cells. Alter-
natively, splenic monocytes, produced in an inflammatory
GM-CSF– and IL-3–rich environment, may differ qualita-
tively from their medullary counterparts. In the present study,
we show that monocytes born in extramedullary sites belong
to the inflammatory subset and express cytokines, reactive
oxygen species, and proteases. They are thus functional and
are known to promote the generation of lesions. Future
studies need to determine whether splenic birth or experience
influences these cells in additional ways.
HSPC mobilization is important to immunosurveillance
and likely plays a role in bone marrow niche reconstruc-
tion.5,45 HSPC differentiation in extramedullary sites may be
essential to the replenishment of dendritic cells and macro-
phages.46 The extramedullary HSPC production of circulating
cells, we now show, contributes importantly to inflammatory
diseases. This shift in the hematopoietic topographical hier-
archy during inflammation is likely to have significant
biological, diagnostic, and therapeutic implications.
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CLINICAL PERSPECTIVE
Atherosclerosis is an inflammatory disease characterized by the accumulation of lipids and leukocytes in the arterial wall.
Monocytes are large circulating leukocytes believed to be essential to the development and exacerbation of atherosclerosis.
As disease worsens, the number of circulating monocytes rises, whereas in models with monocyte depletion,
atherosclerosis neither develops nor evolves. It is believed that hematopoietic progenitors give rise to circulating monocytes
exclusively in the bone marrow. These medullary monocytes circulate, accumulate in tissue, and differentiate to
macrophages or dendritic cells. Extramedullary sites such as the spleen maintain reservoirs of undifferentiated monocytes
that can exit en masse in response to acute inflammation. In this study, we show that during atherosclerosis the bone
marrow outsources the production of monocytes to the spleen. These extramedullary monocytes accumulate in the growing
atheromata. From a clinical perspective, this finding is important because it identifies the spleen as a possible biomarker
organ and therapeutic target for cardiovascular disease, and it proposes that inflammatory hematopoiesis could be targeted
therapeutically in atherosclerosis.
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